celsr2 protein expression overview Search Results


90
Boster Bio anti celsr2
Anti Celsr2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti celsr2/product/Boster Bio
Average 90 stars, based on 1 article reviews
anti celsr2 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc mouse anti bcl2 monoclonal
(a.) Clustering of single cells (n= 2 patients) based upon the top 1000 most highly expressed genes. Both patients are independent of the discovery and validation cohorts; leukemia cells from one patient are sensitive (left) and one resistant to prednisolone (right). Clusters annotated to show CD19+ cells; red denotes control (untreated) and blue depicts cells after treatment with prednisolone 63μM for 96h (b.) CELSR2 expression from clustered single cell populations of sensitive and resistant patients either without treatment or after 96h prednisolone (c.) <t>BCL2</t> expression from clustered single cell populations of sensitive and resistant patients (d.) Bar plot depicting greater proportion of sensitive leukemia cells (n=2,427 control cells; n= 924 treated cells) killed after treatment with prednisolone for 96h compared to resistant patient (n= 686 control cells; n=759 treated cells; two proportion z-test p-value; **** = p <0.0001). (e.) Violin plot representing kernel density of gene expression (individual points represent single cells) of CELSR2 or (f.) BCL2 in CD19+ leukemia cell populations comparing prednisolone treated to untreated cells in sensitive (n=2,427 control cells; n= 924 treated cells) or resistant patients (n= 686 control cells; n=759 treated cells; ** = p <0.01).
Mouse Anti Bcl2 Monoclonal, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti bcl2 monoclonal/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
mouse anti bcl2 monoclonal - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
Shima Laboratories celsr recombinant cadherin repeats celsr2-cr
(a.) Clustering of single cells (n= 2 patients) based upon the top 1000 most highly expressed genes. Both patients are independent of the discovery and validation cohorts; leukemia cells from one patient are sensitive (left) and one resistant to prednisolone (right). Clusters annotated to show CD19+ cells; red denotes control (untreated) and blue depicts cells after treatment with prednisolone 63μM for 96h (b.) CELSR2 expression from clustered single cell populations of sensitive and resistant patients either without treatment or after 96h prednisolone (c.) <t>BCL2</t> expression from clustered single cell populations of sensitive and resistant patients (d.) Bar plot depicting greater proportion of sensitive leukemia cells (n=2,427 control cells; n= 924 treated cells) killed after treatment with prednisolone for 96h compared to resistant patient (n= 686 control cells; n=759 treated cells; two proportion z-test p-value; **** = p <0.0001). (e.) Violin plot representing kernel density of gene expression (individual points represent single cells) of CELSR2 or (f.) BCL2 in CD19+ leukemia cell populations comparing prednisolone treated to untreated cells in sensitive (n=2,427 control cells; n= 924 treated cells) or resistant patients (n= 686 control cells; n=759 treated cells; ** = p <0.01).
Celsr Recombinant Cadherin Repeats Celsr2 Cr, supplied by Shima Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/celsr recombinant cadherin repeats celsr2-cr/product/Shima Laboratories
Average 90 stars, based on 1 article reviews
celsr recombinant cadherin repeats celsr2-cr - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

94
Bio-Rad flamingo1 fluorescent gel stain
(a.) Clustering of single cells (n= 2 patients) based upon the top 1000 most highly expressed genes. Both patients are independent of the discovery and validation cohorts; leukemia cells from one patient are sensitive (left) and one resistant to prednisolone (right). Clusters annotated to show CD19+ cells; red denotes control (untreated) and blue depicts cells after treatment with prednisolone 63μM for 96h (b.) CELSR2 expression from clustered single cell populations of sensitive and resistant patients either without treatment or after 96h prednisolone (c.) <t>BCL2</t> expression from clustered single cell populations of sensitive and resistant patients (d.) Bar plot depicting greater proportion of sensitive leukemia cells (n=2,427 control cells; n= 924 treated cells) killed after treatment with prednisolone for 96h compared to resistant patient (n= 686 control cells; n=759 treated cells; two proportion z-test p-value; **** = p <0.0001). (e.) Violin plot representing kernel density of gene expression (individual points represent single cells) of CELSR2 or (f.) BCL2 in CD19+ leukemia cell populations comparing prednisolone treated to untreated cells in sensitive (n=2,427 control cells; n= 924 treated cells) or resistant patients (n= 686 control cells; n=759 treated cells; ** = p <0.01).
Flamingo1 Fluorescent Gel Stain, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/flamingo1 fluorescent gel stain/product/Bio-Rad
Average 94 stars, based on 1 article reviews
flamingo1 fluorescent gel stain - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

90
GenScript corporation pcdna-3.0-celsr2-gfp(celsr2-gfp)
(a.) Clustering of single cells (n= 2 patients) based upon the top 1000 most highly expressed genes. Both patients are independent of the discovery and validation cohorts; leukemia cells from one patient are sensitive (left) and one resistant to prednisolone (right). Clusters annotated to show CD19+ cells; red denotes control (untreated) and blue depicts cells after treatment with prednisolone 63μM for 96h (b.) CELSR2 expression from clustered single cell populations of sensitive and resistant patients either without treatment or after 96h prednisolone (c.) <t>BCL2</t> expression from clustered single cell populations of sensitive and resistant patients (d.) Bar plot depicting greater proportion of sensitive leukemia cells (n=2,427 control cells; n= 924 treated cells) killed after treatment with prednisolone for 96h compared to resistant patient (n= 686 control cells; n=759 treated cells; two proportion z-test p-value; **** = p <0.0001). (e.) Violin plot representing kernel density of gene expression (individual points represent single cells) of CELSR2 or (f.) BCL2 in CD19+ leukemia cell populations comparing prednisolone treated to untreated cells in sensitive (n=2,427 control cells; n= 924 treated cells) or resistant patients (n= 686 control cells; n=759 treated cells; ** = p <0.01).
Pcdna 3.0 Celsr2 Gfp(celsr2 Gfp), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcdna-3.0-celsr2-gfp(celsr2-gfp)/product/GenScript corporation
Average 90 stars, based on 1 article reviews
pcdna-3.0-celsr2-gfp(celsr2-gfp) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

N/A
Gene Silencers generally consist of pools of three to five target-specific 19-25 nucleotide sequences in length. For independent verification of CELSR2 gene silencing results, individual duplex components or plasmids are also available upon request.
  Buy from Supplier

N/A
Gene Silencers generally consist of pools of three to five target-specific 19-25 nucleotide sequences in length. For independent verification of CELSR2 gene silencing results, individual duplex components or plasmids are also available upon request.
  Buy from Supplier

N/A
The CELSR2 Antibody [Alexa Fluor® 350] from Novus is a CELSR2 antibody to CELSR2. This antibody reacts with Human. The CELSR2 antibody has been validated for the following applications: Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin.
  Buy from Supplier

N/A
The CELSR2 Antibody [Alexa Fluor® 750] from Novus is a CELSR2 antibody to CELSR2. This antibody reacts with Human. The CELSR2 antibody has been validated for the following applications: Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin.
  Buy from Supplier

N/A
The CELSR2 Antibody [DyLight 405] from Novus is a CELSR2 antibody to CELSR2. This antibody reacts with Human. The CELSR2 antibody has been validated for the following applications: Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin.
  Buy from Supplier

N/A
The CELSR2 Antibody [mFluor Violet 450 SE] from Novus is a CELSR2 antibody to CELSR2. This antibody reacts with Human. The CELSR2 antibody has been validated for the following applications: Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin.
  Buy from Supplier

N/A
The Recombinant Human CELSR2 Protein has been validated for the following applications Western Blot ELISA Protein Array Immunoaffinity Purification
  Buy from Supplier

Image Search Results


(a.) Clustering of single cells (n= 2 patients) based upon the top 1000 most highly expressed genes. Both patients are independent of the discovery and validation cohorts; leukemia cells from one patient are sensitive (left) and one resistant to prednisolone (right). Clusters annotated to show CD19+ cells; red denotes control (untreated) and blue depicts cells after treatment with prednisolone 63μM for 96h (b.) CELSR2 expression from clustered single cell populations of sensitive and resistant patients either without treatment or after 96h prednisolone (c.) BCL2 expression from clustered single cell populations of sensitive and resistant patients (d.) Bar plot depicting greater proportion of sensitive leukemia cells (n=2,427 control cells; n= 924 treated cells) killed after treatment with prednisolone for 96h compared to resistant patient (n= 686 control cells; n=759 treated cells; two proportion z-test p-value; **** = p <0.0001). (e.) Violin plot representing kernel density of gene expression (individual points represent single cells) of CELSR2 or (f.) BCL2 in CD19+ leukemia cell populations comparing prednisolone treated to untreated cells in sensitive (n=2,427 control cells; n= 924 treated cells) or resistant patients (n= 686 control cells; n=759 treated cells; ** = p <0.01).

Journal: Nature cancer

Article Title: Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia

doi: 10.1038/s43018-020-0037-3

Figure Lengend Snippet: (a.) Clustering of single cells (n= 2 patients) based upon the top 1000 most highly expressed genes. Both patients are independent of the discovery and validation cohorts; leukemia cells from one patient are sensitive (left) and one resistant to prednisolone (right). Clusters annotated to show CD19+ cells; red denotes control (untreated) and blue depicts cells after treatment with prednisolone 63μM for 96h (b.) CELSR2 expression from clustered single cell populations of sensitive and resistant patients either without treatment or after 96h prednisolone (c.) BCL2 expression from clustered single cell populations of sensitive and resistant patients (d.) Bar plot depicting greater proportion of sensitive leukemia cells (n=2,427 control cells; n= 924 treated cells) killed after treatment with prednisolone for 96h compared to resistant patient (n= 686 control cells; n=759 treated cells; two proportion z-test p-value; **** = p <0.0001). (e.) Violin plot representing kernel density of gene expression (individual points represent single cells) of CELSR2 or (f.) BCL2 in CD19+ leukemia cell populations comparing prednisolone treated to untreated cells in sensitive (n=2,427 control cells; n= 924 treated cells) or resistant patients (n= 686 control cells; n=759 treated cells; ** = p <0.01).

Article Snippet: Primary antibodies used were rabbit anti-CELSR2 monoclonal (Cell Signaling; D2M9H) diluted 1:1,000, mouse anti-BCL2 monoclonal (Cell Signaling;124) diluted 1: 1,000, mouse anti-BIM monoclonal(Cell Signaling;C34C5) diluted 1:1,000, mouse anti GR(BD Biosciences; #611227) diluted 1:1,000, mouse anti p-JNK (Santa Cruz Biotech; sc-6254) diluted 1:500, rabbit anti cJun (Cell signaling; 9165), rabbit anti phospho-cJun Ser63 (Santa Cruz Biotechnology; sc-822 ) diluted 1:500, rabbit anti NFAT1 (Cell Signaling; 4389 ) diluted 1:1,000, SAPK/JNK (Cell Signaling; 9252) diluted 1:1,000, mouse anti GAPDH (Santa Cruz Biotechnology; sc-47724), mouse anti PAX5 (Cell Signaling; 12709) diluted 1:1000mouse anti BCL2 (Cell Signaling; 15071) diluted 1:1000, mouse anti glucocorticoid receptor (BD Biosciences; 611227) diluted 1:1000 rabbit anti LaminB1 (Cell Signaling; 12586) diluted 1:1000 and anti-β-actin (Sigma-Aldrich; A5441) diluted 1:100,000.

Techniques: Expressing